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Cholesterol homeostasis: Clipping out a slippery regulator
Timothy F. Osborne
SREBPs are transcriptional activators central to
cholesterol homeostasis. Recent work has shown that a
two-step cleavage of membrane-bound SREBPs frees
them to enter the nucleus. An activator of the first,
sterol-regulated proteolysis step has also been
identified.
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The metabolism of cholesterol is highly regulated and of
great medical importance. A diet high in fat leads to high
levels of cholesterol in liver cells, repressing the synthesis
of receptors for low density lipoprotein (LDL), a choles-
terol-carrying plasma protein, and so raising the concentra-
tion of cholesterol in the bloodstream. One way in which
the over-accumulation of cholesterol is prevented is the
sterol-regulated degradation of the rate-controlling
enzyme of cholesterol biosynthesis, 3-hydroxy-3-methyl-
glutaryl coenzyme A (HMG CoA) reductase [1]. But of
equal importance here is the regulation of the two sterol
regulatory element binding proteins (SREBPs). Recent
exciting results have shown that an intricate two-step pro-
teolytic pathway ensures that SREBPs, which are ordinar-
ily docked at the membrane, are targeted to the nucleus
only when sterol accumulation is needed [2,3].
The SREBPs were first purified as a mixture of ∼65 kDa
proteins that bound to the cis-acting sterol regulatory
element (SRE) in the promoter of the human LDL
receptor gene (discussed in [2,3] and references therein).
The two cDNAs that were isolated are predicted to
encode highly related products of ∼125 kDa ([4] and refer-
ences therein). Although the need for two SREBPs is still
largely a mystery, evidence from animal feeding experi-
ments indicates that SREBP-1 and SREBP-2 are differen-
tially regulated by dietary perturbation of cholesterol
metabolism [5]. The size difference between the isolated
proteins and the predicted gene products immediately
begs the question of how the ∼65 kDa species are related
to the larger products. The substantial new information
that addresses this question directly links SREBP process-
ing to cholesterol homeostasis. 
The first important observation was that SREBPs are
anchored in a hairpin fashion to the endoplasmic reticu-
lum (ER) membrane as 125 kDa species (Fig. 1). The
amino terminus of each SREBP is in the cytosol, and
includes an acidic transcriptional activation domain linked
to a DNA-binding domain with a basic helix–loop–helix
and a leucine zipper. The two membrane-spanning
helices that follow are separated by a short loop in the ER
lumen, and the carboxyl terminus is found in the cytosol.
Upon sterol depletion, the amount of membrane-attached
125 kDa material decreases and the ∼65 kDa material
accumulates in the nucleus ([6] and references therein).
This is consistent with a precursor–product relationship
between the two species, and indeed the amino-terminal
Figure 1
Structure and regulation of SREBPs. When sterols are present,
SREBPs are localized to the membrane, probably in the ER. Low levels
of sterols trigger the SCAP-dependent cleavage of SREBPs at site 1.
This leads directly to cleavage at site 2, which is dependent on the
target sequence Asp–Arg–Ser–Arg, or DRSR in the one-letter amino
acid code, and release of the amino-terminal domain, which is now free
to enter the nucleus. The SREBPs then bind the SREs in the
promoters of many genes, including those for HMG CoA synthase and
the LDL receptor, and activate their transcription; the SREBPs bind to
the SREs via their basic helix–loop–helix and leucine zipper (bHLH/LZ)
domain.
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segment is released from the membrane by proteolysis
before entering the nucleus and activating transcription of
genes that include those encoding HMG CoA synthase
and the LDL receptor. High levels of cholesterol reduce
the amount of cleavage of the membrane-bound SREBPs,
but increase the degradation of nuclear SREBPs. More
recently, the details of the cleavage process have been
elucidated. SREBPs are released from the membrane
through two sequential proteolytic steps [2,3]. The first
cleavage (at site 1 in Fig. 1) occurs only when sterol levels
fall. Cleavage at site 2 then proceeds rapidly but is
critically dependent on prior cleavage at site 1 [3]. This
second cleavage occurs at residues that are usually in the
middle of the membrane-spanning segment, as does the
cleavage of amyloid precursor protein when amyloid b
protein is formed in Alzheimer’s disease.
Thus, two key cholesterol regulatory proteins are resident
ER membrane proteins and are themselves regulated by
proteolysis. High sterol levels cause the degradation of
HMG CoA reductase and repress the release, and there-
fore activity, of SREBPs. The challenge now is to deter-
mine exactly what the sensing mechanisms are that trigger
SREBP processing and HMG CoA reductase degradation,
whether they are similar or related, and how sterol sensing
is tied to proteolysis. 
A step in this direction was made recently with the identi-
fication of an SREBP cleavage activating protein (SCAP)
[7]. The cells used in this study were from a dominant
oxysterol-resistant line of cultured CHO cells. Oxysterols
are efficient regulators of intracellular cholesterol meta-
bolism, but fail to substitute for cholesterol in cellular
membranes. Thus, when cells are supplied with oxysterol
but starved for cholesterol, they die unless they are insen-
sitive to the regulatory effects of oxysterols. Resistant cells
isolated in this way were used as the source of a cDNA
library, which was used to transfect cells with a luciferase
reporter controlled by tandem SREs. The presence of a
cDNA for a hyperactive SCAP from this library prevented
sterol repression of luciferase expression. When expressed
ectopically, the mutant SCAP stimulated cleavage of
SREBPs more avidly than wild-type SCAP at the correct
lumenal site 1 (Fig. 1). Once this initial clip has occurred,
the second cleavage follows rapidly and the unencum-
bered SREBPs enter the nucleus and activate gene
expression. Apparently, the highly active mutant SCAP
activates SREBP cleavage and cholesterol synthesis even
in the presence of high concentrations of oxysterols that
would inhibit wild-type SCAP and hence kill normal cells. 
The increased activity of the mutant SCAP results from a
missense mutation that changes an aspartate to an
asparagine in a predicted membrane domain. Analysis of
the coding sequence suggested SCAP contains multiple
membrane spans, and indeed wild-type SCAP was
membrane-localized. Surprisingly, the predicted mem-
brane domains of SCAP displayed striking similarity
(55%) to the membrane domain of HMG CoA reductase.
This similarity may reflect the fact that both regions are
sterol sensors, as this region of HMG CoA reductase must
be intact for accelerated degradation of reductase enzyme
in the presence of high sterol concentrations [1]. This
would, in turn, suggest that the ER membrane may be
directly involved in sterol sensing.
The only other clue revealed by sequence comparisons
was the presence of several tryptophan–aspartate (WD)
repeats in SCAP. In other proteins containing WD repeats
— none of which are enzymes — the repeats are known to
be involved in protein–protein interactions. This evidence,
and the fact that SCAP does not share similarity to known
proteases, suggests that SCAP probably functions by
interacting with another protein, perhaps SREBPs, or the
elusive SREBP protease, or both.
SCAP has not yet been localized to a particular membrane
but, given that it functions in SREBP processing and has
similarity to HMG CoA reductase, it is probably an ER
protein. The concentration of cholesterol in the ER
membrane is relatively low and minimal changes in that
concentration, in either direction, could significantly alter
basic membrane properties, such as fluidity and width. It
is possible that SCAP senses the concentration of choles-
terol in the ER membrane and, if the concentration is
below a threshold level, initiates a signaling process culmi-
nating in activation of the site 1 protease. A more thorough
understanding of how SCAP functions in sterol regulation
should be forthcoming from structure–function studies in
cultured cells and gene-targeting experiments in animals.
Membrane-bound SREBPs may be proteolytically activa-
ted by signals other than low levels of intracellular sterols.
SREBPs are involved in the regulation of fatty acid
biosynthesis and SREBP-1 is activated, perhaps to stimu-
late fatty acid biosynthesis, during differentiation of
preadipocytic cells into fat-laden adipocytes in culture ([8]
and references therein). The exact mechanism of activa-
tion and whether different SREBPs are preferentially
activated by distinct signals remain to be determined.
SREBP-1 and SREBP-2 are in vitro substrates for
CPP32/SCA-I and Mch3/SCA-2, homologs of proteases
known to be activated during early stages of programmed
cell death ([9] and references therein). This cleavage
occurs at a site distinct from that recognized by the sterol-
sensing pathway but, as in the sterol-regulated pathway,
the product is predicted to be soluble and targeted to the
nucleus. Consistent with these in vitro data, SREBP-1 and
SREBP-2 were activated by apoptotic signaling through
cleavage at the predicted site in cultured cells. Thus,
SREBPs are activated through at least one other distinct
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signaling process, although the role, if any, for SREBPs
during programmed cell death remains obscure.
The findings discussed above represent important new
advances in our understanding of sterol regulation. Two
other noteworthy advances concerning cholesterol were
reported recently. The first documented that oxysterols
directly activate a novel ligand-activated nuclear receptor
called LXR [10]. The oxysterol activators of LXR are
intermediates in both steroid hormone and bile acid
biosynthetic pathways. It is therefore tempting to specu-
late that LXR activates genes required to convert these
oxysterols efficiently into steroids and bile acids only
when sufficient intermediates are available. LXR appears
to function as a heterodimer along with the retinoid X
receptor (RXR), and the heterodimer is also activated by
certain retinoids. As for many nuclear receptors, the
details of ligand-specific responses are not yet known.
The other new finding documents a novel function for
cholesterol during development. Sonic hedgehog (Shh)
protein, which is involved in intercellular signaling during
early embryonic pattern formation, is known to be lipid-
modified. In the new work, it was suggested that the A
ring hydroxyl group of the sterol nucleus participates as a
nucleophile in the auto-proteolytic processing of Shh
protein [11]. This reaction results in the attachment of
cholesterol to the carboxyl terminus of the active amino-
terminal domain, which should decrease the rate of diffu-
sion of the Shh domain in the extracellular space and thus
restrict the range of action for mature, secreted Shh
protein. This establishes a previously unrecognized and
essential role for cholesterol.
Thus, significant and surprising findings related to choles-
terol and its metabolism surfaced during the past year, and
a strong argument could be made that cholesterol truly
was the ‘molecule of the year’ for 1996.
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